BLUE announcements Bluebird Bio, Inc. announcements and dividends declared USA

Bluebird Bio, Inc. Complete list of announcements declared & dividend announcements by Bluebird Bio, Inc. BLUE

Bluebird Bio, Inc. BLUE listed on USA and deals in Health Care Biotechnology Biological Products No Diagnostic Substances

Announcements and dividends declared by Bluebird Bio, Inc. BLUE

Bluebird bio to lay off nearly one-third of its employees as part of restructuring
Shares of Bluebird bio Inc. fell 0.6% in premarket trading Tuesday, after the gene therapies company announced a restructuring save it 0 million over the next two years but cost 30% of its employees their jobs. With 518 full-time employees as of Jan. 3
Announcement as on 05 April 2022

Bluebird Bio announces partial clinical hold for patients under 18 in sickle cell gene therapy program
Bluebird Bio Inc. said Monday the Food and Drug Administration has placed a partial clinical hold on patients below the age of 18 in its lovo-cel sickle cell gene therapy program. The temporary halt is due to an investigation by the company into an adoles
Announcement as on 20 December 2021

UPDATE: Bluebird Bio announces partial clinical hold for patients under 18 in sickle cell gene therapy program
Bluebird Bio Inc. said Monday the Food and Drug Administration has placed a partial clinical hold on patients below the age of 18 in its lovo-cel sickle cell gene therapy program. The temporary halt is due to an investigation by the company into an adoles
Announcement as on 20 December 2021

bluebird bio Enters Oversold Territory (BLUE)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength
Announcement as on 30 August 2021

Bluebird bio stock surges after FDA lifts clinical hold on studies for sickle cell disease treatments
Shares of Bluebird bio Inc. leapt 7.2% in premarket trading after the gene therapy company said the U.S. Food and Drug Administration (FDA) lifted the clinical holds on the company's trials for its sickle cell disease (SCD) treatments. The lifted hold com
Announcement as on 07 June 2021

Announcements by Bluebird Bio, Inc. first page | Next page | Prev page |

BLUE Bluebird Bio, Inc. current price & indicator signals

Share on: WhatsApp Facebook Tweet